© 2026 Improve the News Foundation.
All rights reserved.
Version 8.2.1
After decades of failed attempts, a new daily pill is offering fresh hope for advanced pancreatic cancer patients by nearly doubling the time they can keep the disease under control. This is a major breakthrough, as most patients survive only a few months. The discovery could also pave the way for new treatments for lung, ovarian and many other cancers by targeting the RAS protein.
The study included only 61 patients and had no control group for comparison, so its findings remain preliminary. Although tumor shrinkage and longer periods without disease progression are encouraging, evidence that the treatment helps patients live longer is still lacking. The phase 3 trial must provide that evidence before the treatment can be called a major breakthrough.